Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy Wolfe Research

Intellia Therapeutics Inc
Start price
€6.94
21.04.25 / 50%
Target price
€18.30
21.04.26
Performance (%)
87.66%
End price
€13.02
22.04.26
Summary
This prediction ended on 22.04.26 with a price of €13.02. The BUY prediction by Wolfe_Research for Intellia Therapeutics Inc saw massive gains of 87.66%. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Intellia Therapeutics Inc 11.663% 11.663% 5.103%
iShares Core DAX® 2.573% 3.502% 8.408%
iShares Nasdaq 100 4.858% 0.654% 28.383%
iShares Nikkei 225® 5.590% -0.246% 52.915%
iShares S&P 500 3.250% 2.083% 24.370%

Comments by Wolfe_Research for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 87.66%
Target price 18.299
Change
Ends at 21.04.26

Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat

Wolfe Research 
0
Report Share
21.04.25
In the thread Trading Intellia Therapeutics Inc
Prediction Buy
Perf. (%) 87.66%
Target price 18.299
Change
Ends at 21.04.26

Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten

Wolfe Research 
0
Report Share
22.04.26